Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New ER-modulatory isoflavonoids for cancer and other conditions

Nov. 6, 2002

Progenics receives funding for development of prostate cancer immunotherapies

Nov. 6, 2002

Epimmune licenses Valentis technology for use in DNA cancer vaccine products

Nov. 6, 2002

SuperGen to begin Orathecin NDA submission by year-end 2002

Nov. 5, 2002

Servier and ConjuChem report novel albumin-binding metalloproteinase inhibitors

Nov. 5, 2002

Progen receives clearance to begin PI-166 clinical trial

Nov. 5, 2002

Pharmacia researchers describe new CDK inhibitors for cancer and other indications

Nov. 5, 2002

Influence of renal dysfunction on safety profile of pemetrexed

Nov. 5, 2002

Pharmacokinetics of epothilone B assessed in patients with advanced cancer

Nov. 5, 2002

Clinical data on the proteasome inhibitor PS-341 in multiple myeloma updated

Nov. 5, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...